Wegovy and Mounjaro: who will actually get reimbursed in France

The two obesity medications Wegovy and Mounjaro could benefit from reimbursement, but access criteria remain highly restrictive.

Published 7sem4 sources✓ ConfirmedNotableupdated 6sem

≈ 24sSpeed

The fact

Social Security is considering limited reimbursement for patients with serious metabolic complications associated with overweight.

These decisions will depend on ongoing negotiations with pharmaceutical manufacturers and recommendations from the French Health Authority.

4 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 4 media sources · identified on May 28, 2026